In 2011 instrument line instrument industry mergers and acquisitions are active

Introduction: In the past three years, mergers and acquisitions in the instrument industry have continued one after another. From the financial crisis of 2009 to the debt crisis in Europe and America in 2011, the economic downturn has created a good environment for mergers and acquisitions, and transaction prices have become more appropriate. According to rough statistics, there were as many as 68 cases of related mergers and acquisitions reported in 2011, and M&A activities generally rose compared to 2010, culminating in a merger and acquisition peak.

More companies become the "protagonist" of mergers and acquisitions

One of the biggest features of the instrument industry M&A event in 2011 was that more and more companies became the “protagonists” of mergers and acquisitions. 44 companies were involved in 68 mergers and acquisitions, of which PerkinElmer made acquisitions in 2011 with 7 mergers and acquisitions. The largest number of companies exceeds Thermo Fisher Scientific, which has been the main business expansion tool for mergers and acquisitions; Agilent Technologies and Thermo Fisher Scientific rank second and third respectively with 6 and 5 M&A events. . In addition, Bruker, Merck Millipore, Oxford Instruments completed three mergers and acquisitions, Sigma-Aldrich, Hammer Group, Spectris Group, GE Healthcare, QuestDiagnostics completed two mergers and acquisitions. More companies have become the protagonists of mergers and acquisitions, and large companies are increasingly adopting mergers and acquisitions strategies to expand or enhance their product lines and technological capabilities.

Judging from the amount of mergers and acquisitions, the biggest deal in the instrument industry in 2011 was Danaher’s $6.8 billion acquisition of Beckman Coulter. Although the transaction amount did not exceed the amount of Thermo acquired by Fisher in 2006, it was also a recent one. Top five deals; the second largest deal is Thermo Fisher's $3.5 billion acquisition of Phadia, and PerkinElmer's $600 million acquisition of CaliperLifeSciences and Sartorius' 68 million euro acquisition of Biohit is also seen as a major acquisition of the instrument industry in 2011. event.

Life sciences become a hot spot for mergers and acquisitions
With the growing market size of the life sciences, particularly the molecular diagnostics business, it is reported that the market size of the life sciences is as high as US$40 billion. Such a large “cake” has attracted foreign major instruments “predators” to align themselves with this market. The field of life sciences has become a hot area of ​​M&A in 2011. The top three deals in the M&A transactions in 2011 took place in the life sciences.

The 2011 M&A scene in the life sciences industry opened from the end of 2010. In December 2010, Beckman Coulter released news that it was interested in selling due to trouble with the recall of testing instruments. Since then, GE, 3M, Danaher, Thermo Fisher, and several private equity funds have all expressed interest in bidding. Nach bid for $6.8 billion. According to statistics, the mergers and acquisitions in the instrument industry throughout the year involved 22 life sciences, accounting for one-third of all mergers and acquisitions in 2011.

In addition, among the top three companies in the instrument industry in 2011, the life sciences also occupied a major position in the mergers and acquisitions they implemented. Among them, there are four Agilent related to the life sciences and three for the Turbo. PerkinElmer has 3 items.

Domestic equipment industry mergers and acquisitions become increasingly active

Compared with frequent mergers and acquisitions in the overseas instrument industry, mergers and acquisitions in the domestic instrument industry are not as active, but they have also become increasingly active in the past two years. After all, they want to become powerful and integration is imperative. Concentration Technology is the most domestic company in mergers and acquisitions strategy. Previously it had acquired Beijing Yingxian, Beijing Ying'an, Beijing Moviteci, Hangzhou Dadi Anke, etc. In 2011, Concentration Technology spent RMB 195 million. The basic price of the acquisition of Beijing Ji Tian, ​​this generous make it become the largest domestic M & A event in the instrument industry in 2011. In the two-year negotiations initiated by Polytec, which started as an agent, Beijing Yuxing Keyi, a manufacturer of fully automated solid phase extraction devices, and Shanghai Test Factory, Dandong Aolong, were acquired.

In addition, domestic instrument companies have also received attention from foreign companies. This year, there were two deals in the acquisition of domestic companies by foreign companies. They were the acquisition of Anhui Longhua Fine Chemicals by U.S. Tiandi Reagent and Zhongjiu Technology by VWR.

Looking forward to 2012, the global economic situation is getting worse, and a number of foreign instrument companies have implemented layoffs. In particular, life science companies are more affected by the economic situation, and there will be more M&A activities by then.